This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Acquired absence of organs, not elsewhere classified
Z21_ACQUI_ABSENCE_ORGANS_NOT_ELSEW_CLASSIFIED
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
428 |
4. Check minimum number of eventsNone |
428 |
5. Include endpointsNone |
428 |
6. Filter based on genotype QC (FinnGen only) |
428 |
Control definitions (FinnGen only)
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z[8-9]
Similar endpoints
↥List of similar endpoints to
Acquired absence of organs, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- Persons with potential health hazards related to family and personal history and certain conditions influencing health status
- Factors influencing health status and contact with health services
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 428 | 192 | 236 |
| Unadjusted period prevalence (%) | 0.09 | 0.07 | 0.10 |
| Median age at first event (years) | 60.99 | 57.35 | 63.96 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 370
- Matched controls
- 3700
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z90.0
ICD-10 Finland
Acquired absence of part of head and neck
+∞
221.9
190
*
Z90.5
ICD-10 Finland
Acquired absence of kidney
+∞
68.9
64
*
Z90.4
ICD-10 Finland
Acquired absence of other parts of digestive tract
+∞
56.7
53
*
Z96.1
ICD-10 Finland
Presence of intraocular lens
41.9
50.8
63
18
127
Kela drug reimbursment
Transplant complication
+∞
41.4
39
*
Z97.0
ICD-10 Finland
Presence of artificial eye
+∞
39.3
37
*
Z94.0
ICD-10 Finland
Kidney transplant status
+∞
38.2
36
*
L04AA06
ATC
mycophenolic acid; systemic
180.5
32.2
33
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
21.2
30.5
45
24
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
22.4
29.0
42
21
CAW99
NOMESCO Finland
Other operation on orbit
+∞
28.5
27
*
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
+∞
28.5
27
*
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
78.2
26.2
29
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.8
25.4
95
249
A12AA04
ATC
calcium carbonate; oral
28.6
25.4
34
13
CDC00
NOMESCO Finland
Enucleation of eye
+∞
25.3
24
*
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
+∞
25.3
24
*
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
+∞
25.3
24
*
A11CC03
ATC
alfacalcidol; systemic
17.1
25.2
40
26
N18.8
ICD-10 Finland
Other chronic renal failure
14.2
25.1
43
34
L04AD01
ATC
ciclosporin; systemic
24.0
24.8
35
16
TK800
NOMESCO Finland
Hemodialysis
18.3
22.7
35
21
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
37.7
22.4
28
8
CDC40
NOMESCO Finland
Evisceration of eye with insertion of prosthesis
+∞
22.1
21
*
ZXE10
NOMESCO Finland
More than one and less than three hours
3.0
21.4
176
858
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
6.9
21.0
54
89
137
Kela drug reimbursment
Uraemia requiring dialysis
81.6
20.9
23
*
ZXD05
NOMESCO Finland
Urgent procedure
3.0
19.9
156
727
Z49.1
ICD-10 Finland
Extracorporeal dialysis
26.3
19.8
27
11
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.2
19.7
49
77
B03XA02
ATC
darbepoetin alfa; parenteral
18.4
19.0
29
17
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.8
19.0
194
1056
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
73.8
18.9
21
*
ZXA00
NOMESCO Finland
Right side
3.0
18.9
138
610
C03CA01
ATC
furosemide; systemic
2.9
18.8
149
692
L04AA01
ATC
[U] ciclosporin; systemic
20.7
18.5
27
14
WX408
NOMESCO Finland
General anesthesy, balanced
3.0
18.4
134
590
S01ED01
ATC
timolol; ophthalmic
8.7
18.3
40
51
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
55.4
18.1
21
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.6
18.1
91
305
Z90.2
ICD-10 Finland
Acquired absence of lung [part of]
+∞
17.8
17
*
CAE10
NOMESCO Finland
Revision and secondary implant in orbit
+∞
17.8
17
*
H05BX01
ATC
cinacalcet; oral
+∞
17.8
17
*
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
38.8
17.8
22
6
ZXE20
NOMESCO Finland
More than three and less than five hours
3.6
17.4
88
295
Z3229
NOMESCO Finland
Other healthcare associate professional
5.2
17.1
55
120
ZX120
NOMESCO Finland
Intravenous
4.4
17.0
65
170
TPH04
NOMESCO Finland
Cathetrisation of vein
3.1
16.9
112
457
Z97.4
ICD-10 Finland
Presence of external hearing-aid
+∞
16.8
16
*
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
177.6
16.6
17
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.6
16.2
172
931
Z90.8
ICD-10 Finland
Acquired absence of other organs
+∞
15.7
15
*
N18.0
ICD-10 Finland
End-stage renal disease
23.3
15.7
22
10
H44.5
ICD-10 Finland
Degenerated conditions of globe
88.9
15.7
17
*
H54.4
ICD-10 Finland
Blindness, monocular
166.7
15.6
16
*
S01EC01
ATC
acetazolamide; systemic
12.6
15.3
27
23
N02AX02
ATC
tramadol; systemic, rectal
2.4
14.8
181
1044
3102
FHL
Enucleation
+∞
14.7
14
*
ZXA05
NOMESCO Finland
Left side
2.7
14.6
125
591
196
Kela drug reimbursment
Paricalcitol and cinacalcet
155.9
14.6
15
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.6
14.5
144
739
S01ED51
ATC
timolol, combinations; ophthalmic
4.9
14.3
48
109
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
9.0
14.3
30
36
B05DA
ATC
Isotonic solutions
55.5
13.9
16
*
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
2.5
13.7
142
742
B05DB
ATC
Hypertonic solutions
78.1
13.7
15
*
Z90.3
ICD-10 Finland
Acquired absence of part of stomach
+∞
13.6
13
*
V03AE02
ATC
sevelamer; oral
+∞
13.6
13
*
Z3231
NOMESCO Finland
Registered nurse
2.6
13.6
124
604
R4110
NOMESCO Finland
Physiotherapy
2.6
13.5
119
566
WX302
NOMESCO Finland
Thoracal epidural anesthesy
5.2
13.4
42
89
TPH07
NOMESCO Finland
Cathetrisation of artery
3.7
13.3
62
192
XCK10
NOMESCO Finland
Photography of fundus of eye
4.0
13.3
56
159
114
Kela drug reimbursment
Glaucoma
4.0
13.3
56
159
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.1
13.1
78
291
M04AA01
ATC
allopurinol; systemic
3.2
12.9
75
274
H54.1
ICD-10 Finland
Severe visual impairment, binocular
+∞
12.6
12
*
CAE00
NOMESCO Finland
Removal of implant from orbit
+∞
12.6
12
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.5
12.5
62
202
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
134.3
12.5
13
*
J01MA02
ATC
ciprofloxacin; systemic
2.3
12.5
162
938
ZXE00
NOMESCO Finland
One hour or less
2.3
12.4
154
874
UJF32
NOMESCO Finland
Coloscopy
2.5
12.2
116
570
L04AX01
ATC
azathioprine; systemic
5.7
12.2
35
67
Z2446
NOMESCO Finland
Social worker
4.5
12.1
43
104
TPX10
NOMESCO Finland
Implantation of vascular injection port
8.4
12.1
26
33
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
4.2
12.0
47
125
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.4
12.0
125
647
Z49.2
ICD-10 Finland
Other dialysis
48.3
12.0
14
*
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
48.3
12.0
14
*
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
7.3
11.9
28
41
WX402
NOMESCO Finland
General anaesthesia
3.0
11.6
73
281
CAE20
NOMESCO Finland
Revision of conjunctival sac with graft
+∞
11.5
11
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.3
11.5
43
110
Z3226
NOMESCO Finland
Physiotherapist
2.7
11.3
89
393
KAC10
NOMESCO Finland
Total nephrectomy with capsule
17.7
11.3
17
10
N02AA05
ATC
oxycodone; systemic
2.9
11.3
77
311
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.3
11.3
136
751
R50.9
ICD-10 Finland
Fever, unspecified
3.0
11.2
70
267
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.6
11.2
39
93
J01MA14
ATC
moxifloxacin; systemic
3.9
11.1
46
129
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
4.6
11.1
38
89
J01DB01
ATC
cefalexin; oral
2.4
11.0
301
2383
S01EA05
ATC
brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)
9.3
10.9
22
25
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
5.2
10.8
33
68
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
4.8
10.7
35
78
J01MA12
ATC
levofloxacin; systemic
2.6
10.7
83
364
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
5.4
10.6
31
61
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
113.1
10.5
11
*
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
+∞
10.5
10
*
Z94.7
ICD-10 Finland
Corneal transplant status
+∞
10.5
10
*
Z90.1
ICD-10 Finland
Acquired absence of breast(s)
+∞
10.5
10
*
K65.0
ICD-10 Finland
Acute peritonitis
12.5
10.5
18
15
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
24.2
10.3
14
6
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.6
10.2
47
144
S01AA01
ATC
chloramphenicol; ophthalmic (antibiotics)
4.5
10.2
36
87
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.5
10.1
89
414
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.2
10.1
129
726
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
41.2
10.0
12
*
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
41.2
10.0
12
*
H54.0
ICD-10 Finland
Blindness, binocular
41.2
10.0
12
*
H02AB04
ATC
methylprednisolone; systemic
2.8
10.0
68
275
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.9
9.9
41
115
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
20.7
9.9
14
7
A02BC02
ATC
pantoprazole; systemic
2.0
9.7
237
1724
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.3
9.7
111
589
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
4.8
9.7
32
72
S01BA01
ATC
dexamethasone; ophthalmic (corticosteroids, plain)
5.7
9.7
27
50
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
56.5
9.7
11
*
TK820
NOMESCO Finland
Peritoneal dialysis
56.5
9.7
11
*
M79.6
ICD-10 Finland
Pain in limb
2.1
9.7
131
753
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
18.1
9.5
14
8
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
102.5
9.5
10
*
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
30.9
9.5
12
*
CJB10
NOMESCO Finland
Laser discission of secondary cataract
4.0
9.4
37
99
Z49.0
ICD-10 Finland
Preparatory care for dialysis
22.4
9.4
13
6
N03AX16
ATC
pregabalin; oral
2.3
9.4
98
500
WX140
NOMESCO Finland
Parabulbar anesthesy
5.6
9.2
26
49
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.6
9.2
74
327
S01BA07
ATC
fluorometholone; ophthalmic (corticosteroids, plain)
11.9
9.1
16
14
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
2.2
9.1
111
607
H02AB06
ATC
prednisolone; systemic
2.0
9.1
176
1163
H3603, E103
ICD-10 Finland
NA
37.7
9.1
11
*
H16.0
ICD-10 Finland
Corneal ulcer
5.2
9.0
27
55
S01FA01
ATC
atropine; ophthalmic
24.7
9.0
12
5
WW200
NOMESCO Finland
Immunization
6.6
8.9
22
35
KA1AE
NOMESCO Finland
Kidney ultrasound examination
7.5
8.9
20
28
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.8
8.7
36
101
H05.0
ICD-10 Finland
Acute inflammation of orbit
51.2
8.7
10
*
D64.9
ICD-10 Finland
Anaemia, unspecified
2.9
8.7
53
199
P01AB01
ATC
metronidazole; oral, rectal
2.0
8.6
138
842
N02BE01
ATC
paracetamol; systemic, rectal
2.2
8.6
306
2527
V03AE01
ATC
polystyrene sulfonate; oral
9.3
8.6
17
19
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
20.6
8.5
12
6
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
5.3
8.5
25
50
S01EX03
ATC
NA
8.2
8.5
18
23
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.2
8.5
44
149
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.0
8.5
145
906
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.5
8.4
73
337
CDC30
NOMESCO Finland
Evisceration of eye
92.0
8.4
9
*
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
92.0
8.4
9
*
321
Kela drug reimbursment
Paricalcitol and cinacalcet
92.0
8.4
9
*
CHF05
NOMESCO Finland
Transscleral laser coagulation of ciliary body
92.0
8.4
9
*
WW500
NOMESCO Finland
Blood transfusion
5.0
8.4
26
55
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
+∞
8.4
8
*
CGG45
NOMESCO Finland
Full thickness transplantation of cornea using homograft
+∞
8.4
8
*
9510/3-C69.2
ICD-O-3
Retinoblastoma, NOS, of retina
+∞
8.4
8
*
H18.1
ICD-10 Finland
Bullous keratopathy
+∞
8.4
8
*
CBF10
NOMESCO Finland
Shortening of canthal ligaments and tarsal plate for ectropion
+∞
8.4
8
*
H57.1
ICD-10 Finland
Ocular pain
5.9
8.3
22
39
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.8
8.2
52
201
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.1
8.2
45
156
S01EC03
ATC
dorzolamide; ophthalmic
12.1
8.1
14
12
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
4.4
8.1
28
67
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.5
8.1
70
321
Z2221
NOMESCO Finland
Medical doctor
2.1
8.1
109
618
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.7
7.9
56
230
C02AC05
ATC
moxonidine; oral
4.5
7.9
27
64
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.7
7.8
33
95
WX110
NOMESCO Finland
Local anesthesy
1.9
7.8
235
1778
A02BC05
ATC
esomeprazole; systemic
1.9
7.8
139
877
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.0
7.8
118
697
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.3
7.8
75
364
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
46.0
7.7
9
*
S01EA02
ATC
dipivefrine; ophthalmic
46.0
7.7
9
*
Z01.8
ICD-10 Finland
Other specified special examinations
2.3
7.7
77
380
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.5
7.7
61
269
S01EC04
ATC
brinzolamide; ophthalmic
6.4
7.6
19
31
U14
ICPC
Kidney symptom/complaint
9.1
7.6
15
17
WX002
NOMESCO Finland
Sedation and analgesia
2.2
7.6
79
399
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
2.8
7.5
47
181
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.1
7.4
28
73
37520
ICD-8 Finland
Glaucoma, Secondary
81.6
7.4
8
*
3643
FHL
Vitrectomy through pars Plana
81.6
7.4
8
*
87011
ICD-8 Finland
Open wound of eye and orbit, Perforans oculi, Complicata
81.6
7.4
8
*
L28
ICPC
Limited function/disability (L)
2.3
7.4
69
329
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.5
7.4
25
59
H02AB07
ATC
prednisone; oral
2.4
7.3
63
287
C69.21
ICD-10 Finland
Retina
+∞
7.3
7
*
3656X
ICD-9 Finland
Glaucoma associated with other ocular disorders[GLAUCOMA SECUNDARIA ALIA SEU NUD]
+∞
7.3
7
*
CDC10
NOMESCO Finland
Enucleation of eye with insertion of prosthesis
+∞
7.3
7
*
M10.3
ICD-10 Finland
Gout due to impairment of renal function
+∞
7.3
7
*
3604
FHL
Penetration of the cornea
+∞
7.3
7
*
S01BC03
ATC
diclofenac; ophthalmic
7.5
7.3
16
22
XCK00
NOMESCO Finland
Perimetry
3.6
7.3
32
96
N05CF01
ATC
zopiclone; oral
1.9
7.2
122
751
R11
ICD-10 Finland
Nausea and vomiting
3.2
7.2
36
119
S01AX11
ATC
[U] ofloxacin; ophthalmic
5.5
7.2
20
38
H02.4
ICD-10 Finland
Ptosis of eyelid
5.5
7.2
20
38
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
20.5
7.2
10
5
GD1AD
NOMESCO Finland
Thorax CT examination
4.2
7.1
26
66
B03XA01
ATC
erythropoietin; parenteral
12.3
7.1
12
10
AA1AD
NOMESCO Finland
CT of head and brain
2.0
7.1
99
564
R53
ICD-10 Finland
Malaise and fatigue
2.2
7.1
79
408
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.8
7.1
46
181
R06.0
ICD-10 Finland
Dyspnoea
2.1
7.1
94
526
RS221
NOMESCO Finland
NA
10.3
7.1
13
13
H26.4
ICD-10 Finland
After-cataract
3.2
7.0
35
116
N03AX12
ATC
gabapentin; oral
2.4
7.0
59
268
A10AE04
ATC
insulin glargine; parenteral
2.8
7.0
44
169
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
7.8
7.0
15
20
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.2
7.0
74
374
SPAT1254
SPAT
Administration of medicine
2.4
6.9
63
295
B01AB10
ATC
tinzaparin; parenteral
3.2
6.9
35
117
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.6
6.9
30
89
SAA03
NOMESCO Finland
Extended examination of mouth
1.9
6.9
128
811
C08CA02
ATC
felodipine; oral
2.8
6.9
43
164
R52.9
ICD-10 Finland
Pain, unspecified
3.1
6.8
38
133
CFD10
NOMESCO Finland
Repair of conjunctiva
40.8
6.8
8
*
V03AE03
ATC
lanthanum carbonate; oral
40.8
6.8
8
*
TCG10
NOMESCO Finland
Removal of sutures from cornea
40.8
6.8
8
*
D31.0
ICD-10 Finland
Benign neoplasm: Conjunctiva
40.8
6.8
8
*
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
17.1
6.8
10
6
C02CA01
ATC
prazosin; oral
7.4
6.8
15
21
KBV00
NOMESCO Finland
Insertion of stent into ureter
23.0
6.7
9
*
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
23.0
6.7
9
*
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.2
6.7
69
347
TKC20
NOMESCO Finland
Catheterisation of bladder
3.0
6.7
38
137
WX100
NOMESCO Finland
Conjunctival surface anesthesia
2.7
6.6
45
179
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
8.9
6.6
13
15
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
8.9
6.6
13
15
I50.9
ICD-10 Finland
Heart failure, unspecified
2.4
6.5
56
256
E21.1
ICD-10 Finland
Secondary hyperparathyroidism, not elsewhere classified
71.0
6.4
7
*
7124
FHL
Nephrectomy (simple
71.0
6.4
7
*
H05.8
ICD-10 Finland
Other disorders of orbit
71.0
6.4
7
*
S05.6
ICD-10 Finland
Penetrating wound of eyeball without foreign body
71.0
6.4
7
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.5
6.4
50
218
I15.9
ICD-10 Finland
Secondary hypertension, unspecified
11.3
6.3
11
10
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
9.5
6.3
12
13
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.8
6.3
164
1152
H40.13
ICD-10 Finland
Chronic glaucoma with open ventricular angle
3.8
6.3
25
69
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
18.4
6.3
9
5
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.0
6.3
93
539
S01EE03
ATC
bimatoprost; ophthalmic
7.2
6.3
14
20
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.7
6.3
43
173
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
5.2
6.3
18
36
5AB14
NOMESCO Finland
NA
+∞
6.3
6
*
Z90.7
ICD-10 Finland
Acquired absence of genital organ(s)
+∞
6.3
6
*
1905A
ICD-9 Finland
Malignant neoplasm of eye, Retina[RETINOBLASTOMA RETINAE]
+∞
6.3
6
*
Z94.2
ICD-10 Finland
Lung transplant status
+∞
6.3
6
*
3608A
ICD-9 Finland
Disorders of the globe, Other disorders of globe[ANOPHTALMIA ARTEFACTA]
+∞
6.3
6
*
CBH30
NOMESCO Finland
Tarsorraphy
+∞
6.3
6
*
TJW99
NOMESCO Finland
Other minor procedure in gastrointestinal endoscopy
+∞
6.3
6
*
TCG00
NOMESCO Finland
Protection of cornea and sclera with soft lens
+∞
6.3
6
*
Z93.2
ICD-10 Finland
Ileostomy status
+∞
6.3
6
*
7151
FHL
Kidney transplantation
+∞
6.3
6
*
J01CA04
ATC
amoxicillin; systemic
1.8
6.2
278
2301
C08CA13
ATC
lercanidipine; oral
2.4
6.2
54
247
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.3
6.2
57
270
L17
ICPC
Foot/toe symptom/complaint
2.0
6.2
89
512
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.9
6.1
102
619
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
4.5
6.1
20
46
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
5.1
6.1
18
37
A02BC01
ATC
omeprazole; systemic
1.9
6.1
103
627
C08CA01
ATC
amlodipine; oral
1.8
6.0
131
868
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.9
6.0
35
129
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003458) Phosphate [Moles/volume] in Serum or Plasma
144
402
4.89
49.23
19.5
4.6
mmol/l
1.1
1.0
2.30
136
367
(3004789) Transferrin [Mass/volume] in Serum or Plasma
137
436
4.15
38.42
5.9
2.3
g/l
2.2
2.3
1.27
127
392
(3022948) Iron [Moles/volume] in Serum or Plasma
141
485
3.84
35.02
6.1
2.3
umol/l
12.0
13.1
0.70
131
441
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
127
415
3.93
33.86
6.3
2.3
%
21.8
22.8
0.25
105
355
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
56
92
6.85
33.59
4.6
3.7
mg/l
1.9
1.5
2.15
51
84
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
88
228
4.60
31.96
10.9
3.3
ng/l
156.7
75.3
3.33
76
202
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
285
1602
3.33
30.82
20.0
6.0
mmol/l
1.2
1.2
0.73
265
1367
(3002032) Base excess in Venous blood by calculation
103
312
4.03
30.30
10.0
3.8
mmol/l
1.7
1.9
0.16
84
236
(3026250) Tacrolimus [Mass/volume] in Blood
28
0
+∞
29.52
49.5
0.0
ug/l
6.8
—
—
28
0
(3000991) Gas panel - Venous blood
93
267
4.17
29.39
13.5
6.7
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
41
56
7.99
28.92
13.0
3.0
iu/ml
307.8
269.7
—
10
7
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
39
52
8.15
28.05
2.5
1.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
67
155
4.94
27.79
9.3
4.4
mmol/l
23.5
24.2
0.85
61
142
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
80
216
4.33
27.34
1.9
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
50
93
5.96
26.38
2.8
2.7
u/ml
0.3
0.4
0.57
22
43
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
260
1467
2.97
26.38
17.7
5.3
mmol/l
1.2
1.2
0.92
250
1334
(3024561) Albumin [Mass/volume] in Serum or Plasma
251
1396
2.93
26.05
12.5
4.2
g/l
34.3
35.5
2.54
231
1301
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
35
45
8.38
25.90
2.5
1.1
u/ml
125.4
95.1
—
13
8
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
36
50
7.77
24.97
2.4
1.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
187
910
2.87
24.63
8.3
4.0
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
60
140
4.82
24.54
2.0
2.2
g/l
1.6
1.5
0.38
49
122
(3007853) Bacteria identified in Skin by Aerobe culture
101
377
3.20
20.99
2.3
1.7
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
34
54
6.75
20.87
1.6
1.1
u/ml
312.6
287.7
0.10
22
22
(3042936) Bacteria identified in Isolate by Culture
109
433
3.04
20.29
2.9
2.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
34
56
6.51
20.15
1.6
1.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
158
776
2.64
19.56
3.1
2.1
mg/l
3.1
3.1
0.13
135
666
(3018418) pH of Serum or Plasma
187
1006
2.53
19.03
14.8
3.7
ph
7.4
7.4
2.89
31
177
(42870588) Differential panel, method unspecified - Blood
192
1050
2.50
18.81
8.5
5.8
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
95
370
3.01
18.15
6.4
2.7
%
1.9
1.8
0.50
84
332
(3009508) Creatinine [Moles/volume] in Urine
186
1017
2.47
18.06
5.2
2.9
mmol/l
6.3
7.8
6.07
166
859
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
218
1284
2.42
17.88
3.6
2.2
nmol/l
74.9
77.6
0.72
207
1143
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
224
1337
2.42
17.81
2.4
2.0
pmol/l
92.2
93.9
0.20
122
700
(3020682) Albumin/Creatinine [Ratio] in Urine
184
1006
2.45
17.81
6.0
3.9
mg/mmol
26.9
8.5
2.75
129
639
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
125
569
2.69
17.79
4.6
2.8
e6/l
2.5
1.8
0.45
81
308
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
264
1699
2.45
17.65
9.1
5.9
umol/l
10.1
11.6
1.98
248
1610
(3026782) Osmolality of Urine
139
670
2.59
17.59
5.1
2.6
mosm/kgh2o
494.9
591.4
5.83
131
562
(3012516) Albumin [Mass/volume] in Urine
175
941
2.45
17.51
5.3
3.1
mg/l
1047.0
187.8
0.99
127
617
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
212
1242
2.40
17.49
7.2
3.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
284
1895
2.48
17.42
13.3
9.2
e9/l
4.4
4.1
1.04
254
1681
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
16
0
+∞
16.77
4.6
0.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
16
0
+∞
16.77
6.6
0.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
217
1307
2.34
16.52
14.2
8.6
inr
1.2
1.2
0.09
68
368
(3006315) Basophils [#/volume] in Blood
252
1628
2.33
16.14
9.1
5.8
e9/l
0.0
0.0
0.16
224
1433
(3030467) Casts [#/volume] in Urine by Automated count
174
961
2.37
16.11
6.3
3.0
e6/l
0.7
0.5
0.27
142
710
(3013115) Eosinophils [#/volume] in Blood
257
1676
2.34
16.07
9.5
6.1
e9/l
0.2
0.2
0.92
232
1504
(3018010) Neutrophils/100 leukocytes in Blood
240
1522
2.31
16.02
9.7
5.8
%
59.2
57.2
1.69
229
1443
(3019198) Lymphocytes [#/volume] in Blood
256
1669
2.33
15.99
9.2
5.9
e9/l
1.8
1.9
0.70
230
1495
(3002582) Erythrocytes [#/volume] in Urine
185
1053
2.33
15.93
6.9
3.1
e6/l
28.1
74.1
2.09
161
801
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
18
18
10.40
15.91
1.4
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
75
275
3.09
15.79
5.3
2.7
e9/l
71.5
69.1
0.22
60
208
(3001604) Monocytes [#/volume] in Blood
250
1620
2.31
15.75
9.1
5.8
e9/l
0.6
0.6
1.77
222
1420
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
19
21
9.42
15.66
1.1
1.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
60
193
3.45
15.64
5.1
3.5
mmol/l
0.8
1.8
0.84
39
142
(3019069) Monocytes/100 leukocytes in Blood
237
1507
2.28
15.56
10.6
6.1
%
8.9
8.8
0.30
228
1427
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
62
205
3.37
15.47
5.0
3.4
kpa
5.1
5.1
0.26
55
186
(3002030) Lymphocytes/100 leukocytes in Blood
241
1546
2.28
15.45
10.1
5.9
%
25.6
27.8
2.25
228
1455
(3018095) Leukocytes [#/volume] in Urine
204
1222
2.28
15.44
8.0
3.6
e6/l
53.9
118.0
1.11
168
865
(3006504) Eosinophils/100 leukocytes in Blood
235
1495
2.27
15.33
10.2
5.8
%
2.9
2.8
0.32
227
1411
(3009343) pH of Capillary blood
61
202
3.36
15.18
5.0
3.4
ph
7.4
7.4
—
10
24
(3016502) Oxygen saturation in Arterial blood
84
336
2.87
15.12
10.3
6.6
%
94.5
95.4
0.52
84
324
(3044640) Blood type and Crossmatch panel - Blood
177
1006
2.29
15.12
3.5
2.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
38
91
4.49
14.92
1.7
1.2
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
229
1455
2.23
14.82
10.2
5.9
%
0.6
0.7
0.42
222
1370
(3052851) Hemolysis interference index of Serum or Plasma
39
96
4.37
14.79
3.4
3.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
176
1010
2.26
14.57
3.8
2.4
u/l
70.9
55.0
0.79
160
936
(3001122) Ferritin [Mass/volume] in Serum or Plasma
213
1322
2.22
14.52
6.2
2.6
ug/l
184.3
134.0
1.36
200
1205
(3003396) Base excess in Arterial blood by calculation
88
369
2.74
14.45
10.2
6.3
mmol/l
0.6
1.2
0.90
73
287
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
123
609
2.43
14.31
4.6
2.7
e6/l
1.1
1.2
0.13
79
345
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
334
2504
2.52
14.28
14.5
7.1
u/l
86.0
79.4
1.05
317
2338
(3026493) Urate [Moles/volume] in Serum or Plasma
152
829
2.29
14.14
4.5
2.6
umol/l
3375.1
7185.5
0.55
136
722
(3017143) Hepatitis C virus Ab [Presence] in Serum
81
329
2.80
14.11
2.9
1.5
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
76
301
2.85
13.87
10.3
7.0
g/l
117.9
121.7
0.78
76
291
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
229
1484
2.17
13.76
6.2
3.9
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
277
1937
2.22
13.67
10.2
4.3
mmol/l
6.8
6.7
0.39
267
1810
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
19
25
7.91
13.66
2.1
2.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
32
72
4.72
13.54
5.2
4.8
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
134
712
2.28
13.10
5.8
2.5
e6/l
3.4
4.6
1.51
122
627
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
90
403
2.56
12.86
2.8
1.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
134
720
2.25
12.70
3.6
2.3
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
17
7
25.19
12.55
2.3
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
17
7
25.19
12.55
2.2
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
159
932
2.12
11.99
6.4
2.9
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
140
785
2.16
11.81
1.8
1.5
nmol/l
20.7
21.1
0.10
122
667
(3019309) Folate [Moles/volume] in Red Blood Cells
118
619
2.25
11.73
2.0
1.8
nmol/l
1235.9
1220.9
0.05
92
473
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
159
942
2.09
11.58
2.7
2.1
u/l
242.6
291.7
0.18
147
894
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
48
162
3.21
11.52
12.4
7.9
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
292
2162
2.10
11.41
7.7
4.3
e6/l
3.2
3168.7
—
9
44
(40758558) Short blood count panel - Blood
143
818
2.12
11.39
8.0
6.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
173
1066
2.05
11.26
4.2
3.2
u/l
33.8
33.2
0.06
162
1019
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
106
547
2.25
10.88
2.9
1.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
23
47
5.11
10.86
1.2
1.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
301
2277
2.08
10.79
8.1
4.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
236
1640
1.98
10.76
8.5
4.9
estimate
0.0
0.0
0.00
39
290
(3035350) Ketones [Presence] in Urine by Test strip
235
1636
1.97
10.60
6.0
3.6
estimate
0.0
0.0
0.49
37
292
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
192
1252
1.97
10.45
4.4
3.4
ng/l
36.1
66.1
0.54
140
875
(3011397) Hemoglobin [Presence] in Urine by Test strip
134
772
2.07
10.32
5.9
3.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
32
89
3.81
10.29
1.3
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
50
185
2.93
10.24
1.4
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
20
38
5.47
10.21
2.1
2.0
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
235
1660
1.92
9.90
6.1
3.7
estimate
0.0
0.0
0.50
38
279
(3011648) Oxygen content in Venous blood
16
25
6.61
9.88
5.1
9.9
%
9.8
11.3
0.74
16
25
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
71
320
2.46
9.87
4.7
3.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
59
246
2.62
9.63
3.7
2.3
ml/min/173m2
48.6
66.0
2.00
23
97
(3013727) Leukocytes other/100 leukocytes in Blood
11
11
10.24
9.58
4.5
4.5
%
56.0
48.9
0.32
11
11
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
39
131
3.18
9.42
2.4
1.8
ug/l
2.5
4.4
0.33
34
115
(3014148) Varicella zoster virus Ab [Titer] in Serum
15
23
6.72
9.41
1.2
1.2
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
45
165
2.93
9.36
9.8
2.9
mmol/l
24.2
24.7
0.40
45
158
(3026008) Bacteria identified in Urine by Culture
157
985
1.94
9.33
3.9
3.0
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
15
24
6.44
9.05
1.6
2.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
35
114
3.25
8.89
3.7
2.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
50
200
2.70
8.85
2.0
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
94
500
2.13
8.79
3.0
1.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
59
258
2.49
8.72
5.1
4.4
%
0.8
0.8
0.04
21
90
(3013707) Erythrocyte sedimentation rate by Westergren method
307
2422
1.95
8.70
6.0
3.9
mm/h
15.4
12.1
2.45
286
2220
(3022313) Gas panel - Capillary blood
40
143
2.98
8.70
4.9
3.6
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
169
1110
1.86
8.58
5.5
3.2
mmol/l
2.3
2.3
1.74
147
970
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
16
29
5.69
8.56
1.9
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
80
404
2.21
8.51
2.4
1.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
145
909
1.90
8.49
2.9
2.8
ng/l
2421.9
1409.7
0.95
128
771
(3008152) Bicarbonate [Moles/volume] in Arterial blood
50
206
2.62
8.34
13.1
6.0
mmol/l
23.9
24.4
0.45
50
191
(3002179) Metamyelocytes/100 leukocytes in Blood
53
226
2.54
8.25
3.5
4.4
%
0.3
0.4
0.19
13
60
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
80
411
2.16
8.13
2.6
1.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
76
383
2.20
8.11
1.7
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
23
60
3.99
8.08
5.0
2.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
115
682
1.94
7.88
1.9
1.7
mg/l
1.7
1.2
0.72
92
532
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
42
164
2.73
7.78
10.6
8.1
mmol/l
24.0
24.6
0.71
42
155
(3021440) Promyelocytes/100 leukocytes in Blood
54
240
2.43
7.69
5.3
4.6
%
0.1
0.2
0.81
19
78
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
64
308
2.27
7.61
3.6
2.0
u/l
29.1
30.0
0.12
57
257
(3021589) Normoblasts [#/volume] in Blood
201
1432
1.76
7.53
16.7
9.4
e9/l
0.0
0.0
0.58
165
1182
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
14
26
5.53
7.29
1.2
1.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
53
240
2.38
7.24
3.1
2.2
g/l
10.5
10.4
0.05
47
220
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
73
378
2.12
7.24
4.2
2.4
umol/l
5.3
8.0
2.11
66
322
(3025159) Blasts/100 leukocytes in Blood
51
227
2.42
7.24
5.5
4.7
%
0.0
0.1
0.68
18
66
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
376
3268
2.24
7.08
36.1
13.5
mg/l
24.6
25.2
0.13
334
2551
(3045414) Leukocytes [Presence] in Urine
35
131
2.82
7.02
2.9
1.9
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
60
293
2.22
6.88
2.8
1.9
nmol/l
329.5
376.3
1.06
55
263
(3000093) Morphology [Interpretation] in Blood Narrative
14
28
5.14
6.75
1.4
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
297
2409
1.76
6.65
4.6
3.6
pmol/l
15.0
14.8
0.34
267
2157
(3022145) Colonoscopy Study observation
67
347
2.10
6.62
1.9
1.3
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
12
21
5.85
6.62
1.7
1.4
u/l
7.7
7.5
—
7
11
(3019060) Gas panel - Arterial blood
48
217
2.37
6.58
7.7
4.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
22
65
3.51
6.51
3.0
1.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
22
65
3.51
6.51
1.1
1.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
15
33
4.67
6.50
2.5
2.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
105
642
1.84
6.42
4.4
3.3
ng/l
299.1
258.4
0.10
90
511
(40768797) Stomach Pathology biopsy report
77
428
1.97
6.27
1.4
1.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
20
57
3.63
6.23
6.0
5.2
%
70.0
60.8
1.17
20
57
(1616796) Gas panel - Central venous blood
20
57
3.63
6.23
8.0
3.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
22
67
3.41
6.22
3.0
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
25
83
3.14
6.18
1.8
1.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
19
53
3.70
6.10
4.3
2.6
%
14.2
16.6
1.52
13
30
(40761535) Cells panel - Urine sediment
56
282
2.13
5.94
5.3
3.4
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
9
6
15.28
5.92
2.9
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
28
102
2.87
5.91
4.1
3.3
g/l
0.5
0.2
1.25
14
39
(3019150) Specific gravity of Urine by Refractometry
117
759
1.75
5.80
5.8
4.0
kg/l
1.0
1.0
0.15
17
103
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
177
1283
1.65
5.79
6.0
3.8
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
381
3393
2.12
5.70
41.5
15.5
mmol/l
139.3
139.7
2.44
372
3305
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
17
46
3.81
5.70
2.9
1.8
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
23
78
3.06
5.50
3.8
2.3
ug/min
211.3
72.3
0.85
17
46
(3023103) Potassium [Moles/volume] in Serum or Plasma
381
3403
2.09
5.50
42.4
15.6
mmol/l
4.0
4.0
4.28
371
3313
(3028026) IgM [Mass/volume] in Serum or Plasma
41
188
2.31
5.45
1.6
1.7
g/l
1.2
1.7
0.63
36
173
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
30
119
2.64
5.42
5.2
4.1
mmol/l
23.6
25.0
0.99
25
113
(3021879) Hepatitis B virus core Ab [Presence] in Serum
43
202
2.25
5.41
1.7
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
19
58
3.38
5.37
9.1
2.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
12
26
4.72
5.29
2.3
2.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
174
1280
1.61
5.24
2.7
2.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
36
159
2.38
5.21
1.5
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
14
35
4.10
5.21
2.5
1.8
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
31
129
2.51
5.09
6.7
5.1
%
0.9
0.9
0.04
31
120
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
31
130
2.49
5.02
6.7
5.1
%
1.6
1.7
0.48
31
120
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
23
83
2.87
4.96
2.7
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
17
51
3.43
4.93
3.3
1.8
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
23
84
2.84
4.86
1.5
1.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
53
284
1.99
4.77
5.2
2.4
g/l
63.5
66.8
1.56
44
255
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
350
3080
1.75
4.76
29.2
12.8
ml/min/173m2
71.0
80.3
6.77
301
2510
(3012501) Base excess in Blood by calculation
18
58
3.20
4.69
9.3
3.4
mmol/l
2.4
3.0
—
10
35
(3013512) EKG study
130
911
1.61
4.69
4.6
3.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
37
175
2.22
4.60
5.5
3.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
127
889
1.61
4.59
6.6
4.0
estimate
0.0
0.0
0.00
36
278
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
44
3.50
4.50
2.4
1.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
55
3.18
4.41
2.4
1.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
256
2111
1.53
4.36
4.6
2.9
u/l
68.6
49.3
1.74
246
1976
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
8
9
9.03
4.29
1.1
1.1
miu/ml
2355.9
1261.3
—
8
9
(21494890) Protein electrophoresis panel - 24 hour Urine
12
31
3.95
4.28
2.5
2.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
14
41
3.50
4.22
2.3
1.7
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
20
74
2.79
4.14
4.0
2.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
15
47
3.27
4.09
2.2
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
15
47
3.27
4.09
1.2
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
21
81
2.67
4.03
1.6
1.4
ug/g
221.1
286.2
0.71
13
46
(3017704) Immunofixation for Urine
9
14
6.54
4.00
1.4
1.8
—
—
—
0
0
(3020891) Body temperature
28
125
2.33
3.99
12.9
3.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
16
54
3.04
3.89
1.9
1.7
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
24
101
2.46
3.89
4.2
4.3
mg/l
66.0
29.8
0.86
19
80
(3034860) Kappa light chains.free [Mass/volume] in Serum
24
101
2.46
3.89
4.2
4.3
mg/l
146.5
68.5
0.40
19
79
(3007164) IgA [Mass/volume] in Serum or Plasma
88
585
1.63
3.86
1.6
1.4
g/l
2.2
2.6
1.14
64
343
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
32
154
2.17
3.83
3.7
3.6
pmol/l
4.3
4.5
0.29
27
136
(40757373) Influenza virus identified in Isolate
6
5
12.14
3.77
1.8
1.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
47
263
1.88
3.74
2.5
2.5
ug/l
5.0
5.6
0.18
38
231
(3002256) Pathology report gross observation
63
386
1.74
3.74
1.3
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
10
25
4.07
3.72
2.6
2.0
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
18
67
2.76
3.70
8.7
6.3
mmol/l
105.3
105.2
0.02
18
59
(3039000) Anion gap in Blood
18
67
2.76
3.70
8.7
6.3
mmol/l
12.0
11.4
0.34
18
59
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
10
26
3.91
3.54
1.2
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
9
17
5.38
3.52
1.8
2.1
—
—
—
0
0
(4035726)
49
287
1.80
3.39
1.5
1.4
—
—
—
0
0
(3016750) Collection duration of Urine
9
18
5.08
3.38
4.0
1.9
min
558.4
468.4
—
9
12
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
9
18
5.08
3.38
1.8
2.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
10
27
3.77
3.37
1.5
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
373
3430
1.68
3.24
32.3
12.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
33
172
2.00
3.24
2.6
2.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
380
3513
1.73
3.22
18.6
9.9
u/l
25.7
26.6
0.53
371
3380
(3051611) Lipemic interference index of Serum or Plasma
10
28
3.63
3.21
3.0
3.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
121
903
1.47
3.12
5.7
3.2
—
—
—
0
0
(3019225) pH of Specimen
47
279
1.77
3.12
11.7
3.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
94
668
1.52
3.07
2.0
1.7
pmol/l
411.9
422.9
0.17
83
551
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
24
113
2.19
3.06
2.5
1.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
334
3009
1.50
3.02
34.2
14.8
%
37.9
40.1
4.10
235
2157
(4306422)
12
40
3.06
2.99
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
16
63
2.60
2.99
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
16
63
2.60
2.99
1.5
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
26
128
2.10
2.98
1.2
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
57
363
1.66
2.95
4.4
4.1
ug/l
49.0
21.2
0.28
49
308
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
328
2951
1.48
2.93
5.9
4.4
mu/l
2.0
1.9
0.73
303
2665
(40760888) Immunoglobulin light chains.free panel - Serum
17
70
2.49
2.91
5.3
5.1
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
9
22
4.16
2.89
1.2
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
22
4.16
2.89
1.8
2.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
12
41
2.98
2.88
1.9
1.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
39
225
1.81
2.85
3.5
2.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
13
47
2.82
2.84
2.9
3.5
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
391
3669
1.76
2.79
48.7
20.1
e9/l
247.0
246.2
0.06
381
3579
(3022621) pH of Urine by Test strip
38
220
1.80
2.76
3.6
2.9
—
—
—
0
0
(3035941) MCH [Entitic mass]
391
3672
1.75
2.74
48.3
20.0
pg
30.3
30.4
0.71
384
3618
(3024731) MCV [Entitic volume]
391
3673
1.75
2.72
48.4
20.0
fl
91.6
91.2
0.80
384
3620
(3026361) Erythrocytes [#/volume] in Blood
391
3673
1.75
2.72
48.5
20.1
e12/l
4.3
4.5
9.85
380
3572
(3008757) Leukocyte morphology finding [Identifier] in Blood
11
37
3.03
2.71
4.7
3.3
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
6
10
6.07
2.70
1.2
2.1
mu/l
9.8
19.5
—
6
10
(3000963) Hemoglobin [Mass/volume] in Blood
391
3675
1.74
2.69
48.9
20.1
g/l
128.2
136.0
14.36
384
3620
(3010813) Leukocytes [#/volume] in Blood
391
3675
1.74
2.69
48.6
20.1
e9/l
7.0
6.7
2.12
380
3571
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
22
106
2.13
2.68
2.1
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
12
44
2.78
2.56
1.3
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
268
2352
1.37
2.56
5.3
3.8
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
6
11
5.51
2.55
2.7
1.0
—
—
—
0
0
(44790047)
10
33
3.08
2.54
2.9
1.4
—
—
—
0
0
(44790048)
10
33
3.08
2.54
2.9
1.4
—
—
—
0
0
(44806118)
10
33
3.08
2.54
2.9
1.4
—
—
—
0
0
(44790049)
10
33
3.08
2.54
2.9
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
59
394
1.58
2.54
1.4
1.3
titre
402.7
456.5
0.17
15
85
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
18
84
2.19
2.38
2.8
2.1
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
5
8
6.31
2.38
5.8
8.3
mg/l
8.3
7.9
—
5
8
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
332
3036
1.42
2.35
8.6
5.6
mmol/mol
41.2
39.7
2.24
310
2814
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
14
59
2.42
2.31
4.2
3.7
%
67.3
57.4
1.53
14
59
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
11
41
2.73
2.29
2.3
1.4
pg
32.9
33.1
0.07
11
41
(4281824)
8
23
3.52
2.28
1.5
1.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
6
13
4.66
2.28
3.0
2.5
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
6
13
4.66
2.28
3.2
1.8
ug/l
40.8
101.5
—
6
13
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
336
3085
1.41
2.27
4.9
3.8
mmol/l
1.4
1.3
3.45
314
2829
(40760892) CBC W Ordered Manual Differential panel - Blood
96
727
1.41
2.24
7.7
4.8
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
9
5.61
2.22
1.8
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
15
67
2.28
2.20
2.3
1.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
19
3.73
2.16
1.0
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
6
14
4.33
2.16
2.5
3.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
25
3.24
2.10
6.3
3.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
8
25
3.24
2.10
3.1
1.9
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
25
3.24
2.10
2.3
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
9
31
2.94
2.08
2.9
1.6
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
10
5.04
2.07
2.4
2.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
10
5.04
2.07
1.2
1.0
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
10
5.04
2.07
1.2
1.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
13
57
2.32
1.99
3.7
3.2
e9/l
5.0
4.3
0.41
13
57
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
22
120
1.88
1.96
1.1
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
224
1960
1.30
1.95
3.7
2.9
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
6
16
3.79
1.94
1.2
3.3
u/l
243.7
220.8
—
6
16
(3042631) Mycobacterium sp identified in Specimen
10
39
2.60
1.93
1.5
2.9
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
18
93
1.98
1.88
1.2
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
8
28
2.89
1.87
3.1
1.6
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
11
46
2.43
1.86
1.5
1.1
pmol/l
438.5
302.9
0.72
11
37
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
10
40
2.54
1.85
1.3
1.2
%
117.6
114.2
—
10
34
(3024263) Appearance of Synovial fluid
5
12
4.20
1.83
1.4
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
12
4.20
1.83
22.6
12.6
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
5
12
4.20
1.83
15.8
4.3
mmol/l
23.0
26.7
—
5
12
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
17
87
1.99
1.82
1.2
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
108
863
1.34
1.80
1.5
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
343
3199
1.36
1.79
5.4
4.2
mmol/l
1.4
1.5
2.44
322
2937
(3017732) Neutrophils [#/volume] in Blood
32
202
1.63
1.77
4.2
2.9
e9/l
3.8
4.0
0.23
23
163
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
18
3.37
1.75
1.3
1.8
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
18
3.37
1.75
1.8
2.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
344
3215
1.36
1.73
5.5
4.3
mmol/l
4.4
4.6
5.08
323
2978
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
5
13
3.88
1.72
1.2
1.1
%
98.6
109.3
—
5
13
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
85
660
1.36
1.70
1.3
1.3
u/ml
1.2
0.9
0.35
30
174
(3014765) Yersinia sp identified in Stool by Organism specific culture
17
90
1.93
1.67
1.2
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
17
90
1.93
1.67
1.1
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
25
151
1.70
1.64
2.9
3.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
15
273
0.53
1.62
2.1
1.8
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
14
3.60
1.62
1.2
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
14
3.60
1.62
1.2
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
84
658
1.34
1.59
3.8
3.1
mmol/l
2.4
2.4
0.05
70
575
(3004451) EKG impression Narrative
6
20
3.03
1.58
1.0
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
8
33
2.45
1.54
1.3
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
18
101
1.82
1.51
1.6
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
10
45
2.25
1.47
1.3
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
349
3294
1.32
1.45
5.9
4.8
mmol/l
2.5
2.7
5.73
328
3018
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
16
3.15
1.44
1.4
1.3
iu/ml
310.6
203.8
—
5
16
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
22
2.75
1.44
3.7
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
22
2.75
1.44
3.7
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
22
2.75
1.44
3.7
1.7
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
9
39
2.34
1.44
1.1
1.1
g/l
1.7
1.5
—
9
34
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
53
394
1.39
1.40
12.8
7.9
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
17
97
1.78
1.37
5.6
4.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
18
294
0.60
1.35
1.2
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
11
54
2.06
1.34
1.7
1.8
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
104
861
1.27
1.32
1.8
1.6
mmol/l
1.6
1.3
1.61
94
733
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
24
2.52
1.31
1.7
1.1
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
16
91
1.79
1.30
2.2
2.0
mg/l
18.0
11.6
1.00
16
85
(3021788) Differential panel - Synovial fluid
9
45
2.02
1.24
1.7
1.8
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
24
156
1.57
1.23
1.3
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
26
2.33
1.19
1.2
1.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
8
38
2.13
1.19
1.9
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
48
365
1.35
1.13
4.7
4.4
%
32.3
31.6
0.21
41
240
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
30
2.35
1.13
1.1
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
30
2.35
1.13
1.1
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
30
2.35
1.13
1.1
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
30
2.35
1.13
1.1
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
10
51
1.98
1.12
1.2
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
31
2.28
1.11
1.1
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
31
2.28
1.11
1.1
1.2
—
—
—
0
0
(4268621)
7
32
2.21
1.08
2.6
2.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
11
59
1.89
1.08
1.2
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
11
191
0.56
1.07
1.5
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
33
2.14
1.06
1.3
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
98
1147
0.81
1.04
3.9
2.8
—
—
—
0
0
(3035880) pH of Pleural fluid
5
22
2.29
1.03
2.2
1.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
131
1.55
1.01
4.2
2.3
g/l
3.4
3.8
0.63
12
100
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
131
1.55
1.01
4.2
2.3
g/l
8.2
7.4
0.82
12
103
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
131
1.55
1.01
4.2
2.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
26
181
1.46
1.01
1.1
1.2
iu/ml
46.3
125.1
—
10
73
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
9
49
1.85
0.99
2.1
1.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
124
1.56
0.98
4.3
2.3
g/l
10.2
10.4
0.03
14
107
(4146454)
5
23
2.19
0.98
1.6
3.2
—
—
—
0
0
(4010399)
31
225
1.41
0.97
1.7
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
36
1.96
0.97
1.1
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
150
1332
1.19
0.97
4.2
4.9
ug/l
4.2
2.5
0.48
136
1173
(3013139) Helicobacter pylori Ag [Presence] in Stool
27
192
1.43
0.95
1.3
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
9
51
1.78
0.95
1.0
2.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
6
27
2.24
0.94
1.5
1.2
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
6
27
2.24
0.94
1.2
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
31
229
1.38
0.89
2.7
1.7
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
10
56
1.80
0.88
1.5
2.6
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
10
57
1.77
0.84
1.5
2.6
mmol/l
4.3
4.1
—
10
57
(3035285) Chloride [Moles/volume] in Venous blood
10
57
1.77
0.84
1.5
2.6
mmol/l
105.1
105.0
—
10
57
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
1.4
—
67.0
—
0
6
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
26
0.00
0.78
0.0
1.0
—
36.4
—
0
14
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
26
0.00
0.78
0.0
1.0
—
266.3
—
0
15
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
26
0.00
0.78
0.0
1.0
—
490.4
—
0
15
(3015171) Extractable nuclear Ab [Units/volume] in Serum
16
107
1.51
0.77
1.0
1.3
—
1.4
—
0
7
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
18
124
1.47
0.76
4.5
2.3
g/l
4.0
3.2
1.58
12
101
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
5
26
1.93
0.71
1.0
1.1
—
—
—
0
0
(4062490)
5
26
1.93
0.71
2.0
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
26
1.93
0.71
1.4
1.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
61
516
1.21
0.67
1.7
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
7
43
1.64
0.67
1.3
1.7
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
29
1.73
0.64
1.0
1.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
12
79
1.53
0.63
1.6
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
5
30
1.67
0.61
1.2
1.7
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
30
1.67
0.61
2.0
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
8
51
1.58
0.60
3.0
1.7
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
8
51
1.58
0.60
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
8
51
1.58
0.60
1.0
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
20
0.00
0.60
0.0
1.1
—
1.1
—
0
13
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
20
0.00
0.60
0.0
2.2
—
3.7
—
0
15
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
12
80
1.51
0.60
1.2
1.2
—
2.6
—
0
11
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
53
1.52
0.58
1.1
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
6
36
1.68
0.57
1.2
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
10
146
0.68
0.53
1.3
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
119
1086
1.13
0.53
4.0
4.4
%
28.1
21.8
2.56
54
538
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
61
531
1.17
0.51
1.3
1.3
u/ml
9.5
10.7
0.07
27
206
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
10
67
1.50
0.50
1.2
1.2
—
1.9
—
0
7
(3017446) Testosterone [Moles/volume] in Serum or Plasma
33
272
1.23
0.49
1.9
2.2
nmol/l
12.8
13.7
0.21
27
245
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
72
801
0.88
0.43
2.1
3.0
ug/l
1.0
0.7
0.65
52
526
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
8
57
1.41
0.42
1.3
1.2
u/l
245.8
12.2
—
8
49
(40761536) Microorganisms panel - Urine sediment
32
268
1.21
0.42
8.2
3.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
16
0.00
0.41
0.0
1.7
—
7.3
—
0
11
(3006653) Thiamine [Moles/volume] in Blood
0
17
0.00
0.40
0.0
1.4
—
146.6
—
0
17
(3026389) Candida sp identified in Specimen by Organism specific culture
5
34
1.48
0.40
1.4
1.4
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
9
66
1.37
0.38
1.6
1.5
—
—
—
0
0
(4034850)
8
113
0.70
0.37
10.3
12.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
328
3202
1.10
0.36
5.8
4.4
mmol/l
6.1
5.9
1.74
296
2909
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
23
276
0.82
0.35
2.5
2.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
43
1.40
0.35
1.0
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
43
1.40
0.35
2.5
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
6
46
1.31
0.33
1.2
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
11
83
1.33
0.32
1.5
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
40
353
1.15
0.31
1.8
1.8
%
1.5
1.5
0.05
33
313
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
7
98
0.71
0.31
1.6
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
8
106
0.75
0.29
2.9
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
8
67
1.20
0.26
1.1
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
9
74
1.22
0.25
1.2
1.2
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
9
74
1.22
0.25
1.7
1.5
e6/l
10.6
48.5
—
9
58
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
9
74
1.22
0.25
1.7
1.6
e6/l
1425.8
173.6
—
9
60
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
11
87
1.27
0.24
1.5
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
6
83
0.72
0.24
1.0
1.8
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
13
156
0.83
0.21
1.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000492) Spirometry study
33
297
1.12
0.21
1.6
1.4
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
52
1.16
0.19
1.2
1.0
—
—
—
0
0
(4094501)
11
91
1.21
0.17
1.3
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
63
1.11
0.17
1.3
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
27
244
1.11
0.16
1.2
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
8
70
1.15
0.16
1.1
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
8
71
1.13
0.16
3.3
1.7
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
9
80
1.13
0.15
1.7
1.5
mu/l
321.2
290.3
—
9
74
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
25
274
0.91
0.14
1.2
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
10
117
0.85
0.13
1.3
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
9
106
0.85
0.13
2.8
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
9
107
0.84
0.13
2.8
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
9
107
0.84
0.13
2.8
1.5
—
—
—
0
0
(1002224) Polysomnography panel
12
137
0.87
0.12
1.3
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
18
162
1.12
0.12
2.1
1.9
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
11
97
1.14
0.09
1.5
2.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
32
302
1.06
0.08
2.3
2.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
20
185
1.09
0.08
1.5
1.3
—
30.3
—
0
14
(3050129) First trimester maternal screen panel - Serum or Plasma
5
65
0.77
0.08
1.6
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
76
1.05
0.07
1.0
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
7
85
0.82
0.07
1.0
1.0
—
3.9
—
0
11
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
12
110
1.09
0.05
1.7
1.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
57
560
1.02
0.02
1.3
1.3
iu/ml
23.2
38.7
0.88
14
177
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
13
132
0.98
0.00
2.3
1.9
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
21
213
0.99
0.00
2.7
2.5
—
16.8
—
0
9
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
34
335
1.02
0.00
1.6
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
40
395
1.01
0.00
1.6
1.4
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
6
0.00
0.00
0.0
3.7
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
22.2
—
0.5
—
0
6
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(4133840)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
7
78
0.90
0.00
1.1
1.3
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
7
0.00
0.00
0.0
7.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
9
97
0.93
0.00
2.8
1.5
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
82
0.98
0.00
2.9
1.6
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
26.2
—
0
5
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
84
0.95
0.00
2.0
1.3
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
2.8
—
0.4
—
0
5
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
19.5
—
0
5
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
6
66
0.91
0.00
1.3
1.1
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
7
0.00
0.00
0.0
3.9
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
2.0
—
0
5
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_ACQUI_ABSENCE_ORGANS_NOT_ELSEW_CLASSIFIED – Acquired absence of organs, not elsewhere classified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).